Variable | SII | ||||||||
---|---|---|---|---|---|---|---|---|---|
Training cohort | Validation cohort | Combined cohort | |||||||
< 484.5 | ≥ 484.5 | P | < 484.5 | ≥ 484.5 | P | < 484.5 | ≥ 484.5 | P | |
No. of patients | 96 | 42 | Â | 105 | 66 | Â | 201 | 108 | Â |
Age (y) | |||||||||
 ≤ 60 | 36 | 11 | 0.197 | 38 | 27 | 0.536 | 74 | 38 | 0.776 |
 > 60 | 60 | 31 |  | 67 | 39 |  | 127 | 70 |  |
Gender | |||||||||
 Male | 53 | 28 | 0.208 | 51 | 39 | 0.180 | 104 | 67 | 0.083 |
 Female | 43 | 14 |  | 54 | 27 |  | 97 | 41 |  |
Smoking | |||||||||
 No | 61 | 28 | 0.724 | 83 | 50 | 0.614 | 144 | 78 | 0.914 |
 Yes | 35 | 14 |  | 22 | 16 |  | 57 | 30 |  |
Alcohol use | |||||||||
 No | 70 | 34 | 0.313 | 90 | 51 | 0.158 | 160 | 85 | 0.853 |
 Yes | 26 | 8 |  | 15 | 15 |  | 41 | 23 |  |
Tumor size | |||||||||
 T1–T2 | 78 | 25 | 0.007 | 88 | 47 | 0.049 | 166 | 72 | 0.002 |
 T3–T4 | 18 | 17 |  | 17 | 19 |  | 35 | 36 |  |
Pathological grade | |||||||||
 I | 61 | 22 | 0.218 | 63 | 32 | 0.140 | 124 | 54 | 0.047 |
 II–III | 35 | 20 |  | 42 | 34 |  | 77 | 54 |  |
Cervical nodal metastasis | |||||||||
 N0 | 78 | 34 | 0.967 | 73 | 48 | 0.654 | 151 | 82 | 0.876 |
 N+ | 18 | 8 |  | 32 | 18 |  | 50 | 26 |  |
Clinical stage | |||||||||
 I–II | 65 | 26 | 0.508 | 65 | 35 | 0.252 | 130 | 61 | 0.157 |
 III–IV | 31 | 16 |  | 40 | 31 |  | 71 | 47 |  |